Dechoker’s overwhelming success drives full compliance to FDA requirements.

It’s no surprise that Dechoker’s revolutionary airway clearing device is getting attention. As sales have ramped up so have reported life saves from its device. In the past weekend, the Dechoker team was a buzz with 6 new life saves coming in just three days. Dechoker’s Vice President Sean Pittman says “Saving lives is an important thing, it's not every day you get to be a part of that.” But the work of creating a life-saving device is an arduous one and something the entire Dechoker team is dedicated to. 

Creating an invention, something that has not been done before comes with a lot of hurdles especially when it is one that is regulated by the FDA. Throughout Dechoker’s history, the process and development of the device have gone through many stages, many of the early ones were just trying to get a device that had an advantage and was effective in the first aid protocol of a choking victim. There were many setbacks along the way but each step backward helped the company move forward with a better, safer, and more effective product. CEO Alan Carver says his goals remain the same, “Continuous improvement to provide a safe and effective device that helps eradicate choking deaths.” 

Dechoker’s FDA Response

Dechoker is proud to be a homegrown independent medical device manufacturing company in Denver, Colorado. With the independent mindset came some learning curves in how to manufacture a device that is regulated by the FDA. Thankfully the FDA has helped Dechoker with our processes and we consider their input a vital piece to Dechoker’s future success. 

Throughout this process, Dechoker has focused on bringing on first-class quality management engineers and design engineers to document, manage and drive strict adherence to FDA protocols. With the help of this talented team, we are working towards implementing all recommendations set forth by the FDA with regards to our Quality Management Systems. Dechoker's Quality Team provides monthly updates to the FDA and continues to work towards full FDA compliance. 

Dedicated Medical Board

Dechoker knows it is imperative to have a dedicated medical board that drives fundamental medical recommendations for the Dechoker device. Our global medical board consists of five doctors with each one having unique medical credentials and all of them contributing to the success of our medical device, the Dechoker. In addition to being backed by published clinical studies, our medical board provides a strong recommendation for the Dechoker device. 

Dechoker’s Move Toward EU-MDR, MDSAP, and Global Markets 

The next step in Dechoker’s journey is obtaining the EU-MDR. The EU-MDR is the regulatory body of the European Union which approves the sale of medical devices. There are 27 EU member countries and Dechoker looks forward to penetrating these markets.

Dechoker would also like to obtain the Medical Device Single Audit Program (MDSAP) this is a program that allows a single regulatory audit of a medical device manufacturer’s quality management system that satisfies the requirements of multiple regulatory jurisdictions. The MDSAP is a way that medical device manufacturers can be audited once for compliance with the standard and regulatory requirements of up to five different medical device markets: Australia, Brazil, Canada, Japan and the United States. Dechoker’s team has all the necessary documentation in place for this and expects a decision on this big step by the end of the year.